Active Government Funding Opportunities

DoD seeks innovative, high-risk autism research to accelerate discoveries and improve outcomes for autistic individuals. This award supports novel ideas with potential to generate impactful data and open new investigation pathways.

The Army seeks collaborative melanoma research teams to advance understanding and treatment of melanoma through innovative scientific approaches. This team science award supports competitive research that addresses critical gaps in melanoma biology and clinical outcomes.

Support clinical trials evaluating new treatments, devices, and approaches for autism management. Awards fund proof-of-concept through large-scale efficacy studies, with funding incentives for early-career researchers partnering with experienced mentors.

Support early-career researchers conducting innovative autism studies and proof-of-principle clinical trials. This award funds high-impact research ideas with required community partnership to advance autism understanding and treatment.

This Army Medical Research funding supports translational research addressing health impacts from toxic exposures on military personnel. Projects bridge discovery science to clinical solutions for affected service members and veterans.

The Army seeks innovative technologies and therapeutic approaches to treat severe burn injuries in military personnel. This award funds development of novel burn treatment solutions from basic research through clinical application.

This award funds translational research bridging discoveries in traumatic brain injury (TBI) and psychological health toward clinical applications. Research aims to advance understanding and treatment of TBI-related mental health conditions in military populations.

This Army funding opportunity supports investigator-initiated research into toxic exposures affecting military personnel, seeking novel scientific studies to understand health impacts and inform prevention strategies.

This Army award supports melanoma survivorship research, focusing on improving quality of life and long-term outcomes for cancer survivors. It seeks studies addressing post-treatment complications, psychosocial factors, and evidence-based interventions for melanoma patients.

The Army seeks patient-centered research to advance burn treatment and recovery outcomes for military personnel. This funding supports innovative clinical studies and therapeutic approaches to improve care for burn-injured soldiers.

The Army seeks innovative research on military burn treatment and prevention through discovery-phase awards. This funding targets novel solutions to improve clinical outcomes for service members with severe thermal injuries.

The Army seeks melanoma research to advance understanding and treatment of this serious cancer. This Scholar Award supports innovative scientific studies that could improve patient outcomes and military medical capabilities.

The Army seeks clinical trial research to advance traumatic brain injury and psychological health treatments for service members. This funding supports evidence-based interventions to improve diagnosis, prevention, and recovery outcomes.

This award supports health services research addressing traumatic brain injury and psychological health outcomes in military populations. It seeks evidence-based studies to improve clinical care delivery and patient outcomes for service members.

This award supports clinical trials investigating health outcomes and treatments for service members exposed to toxic substances during military operations. The research aims to establish evidence-based interventions and improve medical care for affected veterans.

Develop advanced communications and networking technologies to enable seamless, secure connectivity for distributed naval operations across manned and unmanned platforms. Address challenges like jamming, spectrum limitations, and infrastructure constraints to support real-time command and control.

Develop research resources, datasets, and infrastructure to advance rare cancers research and treatment outcomes. Supports patient tissue repositories, tumor models, data-sharing platforms, and community engagement strategies.

DoD seeks groundbreaking novel concepts to advance rare cancer research and treatment. This concept award supports highly innovative, untested ideas without requiring preliminary data, enabling early-stage exploration of potentially transformative approaches.

The Army seeks applied research innovations in orthopaedic medicine to advance soldier health and readiness. This award funds development of new treatments, devices, or technologies addressing musculoskeletal injuries and combat-related orthopedic conditions.

Seeking early-stage research to develop novel therapies for Duchenne muscular dystrophy across all age groups, from infants to nonambulatory individuals. High-risk/high-reward studies with strong preliminary data that could accelerate near-term clinical outcomes.

DoD seeks development of a multiomic atlas from human bone marrow failure samples to create an open-access research resource. This dataset will enable discoveries advancing understanding of bone marrow failure diseases across the research and clinical community.

This DoD funding supports early-stage rare cancer research ideas with potential for high-impact discoveries. The program welcomes exploratory approaches and accepts preliminary data from related disease studies to advance novel investigation pathways.

The Army seeks orthopaedic clinical research to advance musculoskeletal injury treatment and recovery for military personnel. This award funds innovative studies addressing combat-related and service-connected orthopaedic conditions.

Supports investigator-initiated research advancing bone marrow failure treatments through translational and clinical studies. Funds mature ideas with IND-enabling efforts and correlative research to drive significant patient care improvements.

Support innovative research to understand and cure bone marrow failure diseases through scientifically sound approaches. Open to established and early-career investigators; preliminary data not required.